These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 32293401)

  • 1. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
    Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
    Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of Ultrasound-Guided Fine-Needle Aspiration Cytology Combined with Puncture Feeling in the Diagnosis of Thyroid Nodules.
    Li L; Chen X; Li P; Liu Y; Ma X; Ye YQ
    Acta Cytol; 2021; 65(5):368-376. PubMed ID: 34350849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy Rates in Thyroid Nodules Classified as Bethesda III and IV; Correlating Fine Needle Aspiration Cytology with Histopathology.
    Pereira C
    Prague Med Rep; 2022; 123(4):243-249. PubMed ID: 36416462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules.
    Jooya A; Saliba J; Blackburn A; Tamilia M; Hier MP; Mlynarek A; Forest VI; Rochon L; Florea A; Wang H; Payne RJ
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):51. PubMed ID: 27756425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
    Choden S; Wangmo C; Maharjan S
    Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of Malignancy in Cytology Indeterminate Thyroid Nodules: A Single Center Surgical Series.
    Baraf L; Avidor Y; Bahat Dinur A; Yoel U; Samueli B; Joshua BZ; Fraenkel M
    Isr Med Assoc J; 2023 Feb; 25(2):147-151. PubMed ID: 36841986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
    Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
    Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
    Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of ultrasound-guided fine-needle aspiration cytology in evaluation of thyroid nodules using different ultrasonographic and cytological features.
    Al-Yousofy F; Hamood M; Almatary AM; Mothanna A; Al-Wageeh S; Nasher ST; Alselwi A; Hassan H; Al-Yousofy A; Ahmad RH
    Cytopathology; 2024 Nov; 35(6):738-748. PubMed ID: 39001663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
    Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
    Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of the thyroid nodule with Bethesda indeterminate cytology, category III, IV, V on the one surgeon-performed US-guided fine-needle aspiration with 27-gauge needle, verified by histopathology of thyroidectomy: the additional value of one surgeon-performed elastography.
    Sengul D; Sengul I; Van Slycke S
    Acta Chir Belg; 2019 Feb; 119(1):38-46. PubMed ID: 30606092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience.
    Köseoğlu D; Özdemir Başer Ö; Çetin Z
    Diagn Cytopathol; 2021 Oct; 49(10):1110-1115. PubMed ID: 34196509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center.
    Godoi Cavalheiro B; Kober Nogueira Leite A; Luongo de Matos L; Palermo Miazaki A; Marcel Ientile J; Aurelio V Kulcsar M; Roberto Cernea C
    Int J Endocrinol Metab; 2018 Jan; 16(1):e12871. PubMed ID: 29696036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.
    Cherella CE; Angell TE; Richman DM; Frates MC; Benson CB; Moore FD; Barletta JA; Hollowell M; Smith JR; Alexander EK; Cibas ES; Wassner AJ
    Thyroid; 2019 Aug; 29(8):1097-1104. PubMed ID: 31298618
    [No Abstract]   [Full Text] [Related]  

  • 18. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.